Yossi Maimon | Chief Financial Officer |
Moshe Manor | President, Chief Executive Officer and Director |
Raghuram Selvaraju | H.C. Wainwright & Co., LLC |
Peter Welford | Jefferies & Company |
Ian Scime | Highbridge Capital Management |
Good day, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Year End 2017 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a Q&A session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Mr.